Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

All cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with TNF antagonists.

02/01/2008

Carmona L, Descalzo MA, Perez-Pampin E, Ruiz-Montesinos D, Erra A, Cobo Ibanez T, Gomez-Reino JJ, Study Groups EB.

Descargar documento

Ann Rheum Dis. 2007 Feb 26;